These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36215918)

  • 1. Relationship between CYP2C19*2, *3 gene polymorphism and the recurrence in ischemic stroke patients treated with clopidogrel in China: A meta-analysis.
    Yan Y; Hao R; Zhao X; Xia X; Wang L; Li X
    J Stroke Cerebrovasc Dis; 2022 Nov; 31(11):106798. PubMed ID: 36215918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association of CYP2C19 gene polymorphisms with long-term recurrent risk of ischemic stroke among ethnic Han Chinese from Fujian].
    Fang L; Zhao Y; Wang N; Yang Z; Huang H; Lin M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Dec; 32(6):871-6. PubMed ID: 26663068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation between recurrent risk and CYP2C19 gene polymorphisms in patients with ischemic stroke treated with clopidogrel for prevention.
    Liu G; Yang S; Chen S
    Medicine (Baltimore); 2020 Mar; 99(11):e19143. PubMed ID: 32176040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of CYP2C19 polymorphism in prognosis of minor stroke or TIA patients with declined eGFR on dual antiplatelet therapy: CHANCE substudy.
    Wu Y; Zhou Y; Pan Y; Zhao X; Liu L; Wang D; Wang C; Li H; Johnston SC; Meng X; Wang Y; Wang Y;
    Pharmacogenomics J; 2018 Dec; 18(6):713-720. PubMed ID: 29520080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and safety of aspirin-ticagrelor vs. aspirin-clopidogrel in ischemic stroke patients with cerebral artery stenting.
    Liu C; Liu M; Yang X; Luo T; Wang J; Li G
    Clin Neurol Neurosurg; 2024 Apr; 239():108229. PubMed ID: 38479036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant Use of Proton Pump Inhibitors and Clopidogrel Is Not Associated with Adverse Outcomes after Ischemic Stroke in Chinese Population.
    Yi X; Zhou Q; Wang C; Lin J; Cheng W; Chi L
    J Stroke Cerebrovasc Dis; 2016 Dec; 25(12):2859-2867. PubMed ID: 27546731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of CYP2C19 LoF alleles with adverse clinical outcomes in stroke patients taking clopidogrel: An updated meta-analysis.
    Biswas M; Hossain MS; Ahmed Rupok T; Hossain MS; Sukasem C
    Clin Transl Sci; 2024 Apr; 17(4):e13792. PubMed ID: 38581109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variants in clopidogrel-relevant genes and early neurological deterioration in ischemic stroke patients receiving clopidogrel.
    Yi X; Zhou Q; Zhang Y; Zhou J; Lin J
    BMC Neurol; 2020 Apr; 20(1):159. PubMed ID: 32345264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Cytochrome P450 Genetic Variants with Clopidogrel Resistance and Outcomes in Acute Ischemic Stroke.
    Yi X; Lin J; Wang Y; Zhou Q; Wang C; Cheng W; Chi L
    J Atheroscler Thromb; 2016 Oct; 23(10):1188-1200. PubMed ID: 26961113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Genetic Polymorphisms on Clopidogrel Response and Clinical Outcomes in Patients with Acute Ischemic Stroke CYP2C19 Genotype on Clopidogrel Response.
    Han Y; Lv HH; Liu X; Dong Q; Yang XL; Li SX; Wu S; Jiang JM; Luo Z; Zhu DS; Zhang Y; Zheng Y; Guan YT; Xu JF
    CNS Neurosci Ther; 2015 Sep; 21(9):692-7. PubMed ID: 26177117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual therapy with clopidogrel and aspirin prevents early neurological deterioration in ischemic stroke patients carrying CYP2C19*2 reduced-function alleles.
    Lin J; Han Z; Wang C; Yi X; Chai Z; Zhou Q; Huang R
    Eur J Clin Pharmacol; 2018 Sep; 74(9):1131-1140. PubMed ID: 29804161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP2C19 metabolizer status and clopidogrel efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) study.
    McDonough CW; McClure LA; Mitchell BD; Gong Y; Horenstein RB; Lewis JP; Field TS; Talbert RL; Benavente OR; Johnson JA; Shuldiner AR
    J Am Heart Assoc; 2015 May; 4(6):e001652. PubMed ID: 26019129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial.
    Pan Y; Chen W; Wang Y; Li H; Johnston SC; Simon T; Zhao X; Liu L; Wang D; Meng X; Wang Y;
    JAMA Neurol; 2019 May; 76(5):552-560. PubMed ID: 30742211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body weight, CYP2C19, and P2Y12 receptor polymorphisms relate to clopidogrel resistance in a cohort of Chinese ischemic stroke patients with aspirin intolerance.
    Li Z; Dong W; Yang D; Sun L; He X; Hu H; Zhang J; Wang C; Li Y; Zhao M; Kong Y; Wang Y
    Eur J Clin Pharmacol; 2020 Nov; 76(11):1517-1527. PubMed ID: 32632713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between platelet function and recurrent ischemic vascular events after TIA and minor stroke
.
    Zhang J; Zhang J; Sun H; Ming T; Liu X; Cong Y; Li F; Li Z
    Int J Clin Pharmacol Ther; 2017 Oct; 55(10):789-797. PubMed ID: 28766499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variant recurrent risk among stroke patients with different CYP2C19 phenotypes and treated with clopidogrel.
    Sun W; Li Y; Li J; Zhang Z; Zhu W; Liu W; Cai Q; Wang X; Cao L; Bai W; Fan X; Ma M; Guo R; Liu X; Xu G
    Platelets; 2015; 26(6):558-62. PubMed ID: 25207801
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Sun Y; Lu Q; Tao X; Cheng B; Yang G
    Front Genet; 2020; 11():576046. PubMed ID: 33414804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Platelet Therapy in Mild Cerebral Infarction Patients on the Basis of CYP2C19 Metabolizer Status.
    Lan H; Ying T; Xi-Hua S; Yi L
    Cell Transplant; 2019 Aug; 28(8):1039-1044. PubMed ID: 31134829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated with clopidogrel.
    Jin B; Ni HC; Shen W; Li J; Shi HM; Li Y
    Mol Biol Rep; 2011 Mar; 38(3):1697-702. PubMed ID: 20845077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP2C19 Polymorphism is Associated With Amputation Rates in Patients Taking Clopidogrel After Endovascular Intervention for Critical Limb Ischaemia.
    Lee J; Cheng N; Tai H; Jimmy Juang J; Wu C; Lin L; Hwang J; Lin J; Chiang F; Tsai C
    Eur J Vasc Endovasc Surg; 2019 Sep; 58(3):373-382. PubMed ID: 31395432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.